Diabetes & Metabolism Journal10.4093/dmj.2020.00572021454505-514Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes MellitusJa Young Jeon, Kyoung Hwa Ha, Dae Jung Kim,,
Diabetes, Obesity and Metabolism10.1111/dom.130472017201113-120Efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors as monotherapy or add‐on to metformin in patients with type 2 diabetes mellitus: A systematic review and meta‐analysisZhiying Wang, Jiahui Sun, Ruobing Han, Dongzhu Fan, Xinyi Dong, Zenghui Luan, Rongwu Xiang, Mingyi Zhao, Jingyu Yang,,,
Diabetes10.2337/db19-160-lb201968Supplement_1160-LB: Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Hemodynamic and Metabolic Cardiovascular Markers in Patients with Type 2 Diabetes MellitusNATTAPOL SATHAVARODOM,
Diabetes10.2337/db22-125-lb202271Supplement_1125-LB: Individualized Cost-Effectiveness Assessment of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i) vs. Sulfonylureas as Add-On Therapy in People with Inadequately Controlled Type 2 Diabetes (T2D) Under Metformin MonotherapyDAWEI GUAN, SHU NIU, VIVIAN FONSECA, LIZHENG SHI, NEDA LAITEERAPONG, JINGCHUAN GUO, HUI SHAO,
Diabetes/Metabolism Research and Reviews10.1002/dmrr.24942014304269-283The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysisPaweł Kawalec, Alicja Mikrut, Sylwia Łopuch,
Value in Health10.1016/j.jval.2016.09.18342016197A665An Assessment of The Relative Efficacy of Sodium Glucose Co-Transporter 2 Inhibitors As Add-On To Metformin In Patients With Type 2 Diabetes MellitusC Whittington, A Schubert, C Neslusan,
Revista Clínica Española (English Edition)10.1016/j.rceng.2019.09.0112020220124-26Metformin and sodium-glucose cotransporter inhibitors as therapy for type 1 diabetes mellitus: Handle with careJ. Ena, R. Gómez-Huelgas,
The Diabetes Educator10.1177/01457217156076432015411_suppl5S-18SSodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Type 2 Diabetes MellitusEva Vivian,,
Diabetes, Obesity and Metabolism10.1111/dom.13477201821128-36Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetesGhadeer K. Dawwas, Steven M. Smith, Haesuk Park,
Value in Health10.1016/j.jval.2019.09.2750201922121458-1469Cost Utility of Sodium-Glucose Cotransporter 2 Inhibitors in the Treatment of Metformin Monotherapy Failed Type 2 Diabetes Patients: A Systematic Review and Meta-AnalysisBhavani Shankara Bagepally, Yogesh Krishnarao Gurav, Thunyarat Anothaisintawee, Sitaporn Youngkong, Usa Chaikledkaew, Ammarin Thakkinstian,